ELTX
Elicio Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.87 / 10
Netural
Analyst consensus is 100% Strong Buy from two analysts, though their historical win rates are 0% and 33%. Fund‑flow score is 7.42 (good) but all size‑segment trends are negative. Mixed sentiment suggests cautious optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-10
InstitutionRodman & Renshaw
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of ELTX?
- ELTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.87/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
